ReGen is an early-stage biopharmaceutical company developing Colostrinin (a natural sourced material) for Alzheimers. Colostrinin may also have utility as a neutraceutical More
Kalight is devoted to developing patents dealing with viral CNS conditions and seeking licensees and partnerships. Currently, it is marketing its patent for certain herpes neurological conditions. More
"We Have New Ideas" Schwarz Pharma USA is experiencing explosive growth in the U.S. We are aggressively seeking in-licensing opportunities in CNS, GI, Cardiovascular and Urology markets More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Displaying 1..10 of 49 -
per page
Next page
Order by